» Articles » PMID: 9072705

Successful Use of Hydroxyurea in Beta-thalassemia Major

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1997 Mar 27
PMID 9072705
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

Efficacy of Hydroxyurea in Transfusion-Dependent Major β-Thalassemia Patients: A Meta-Analysis.

Hatamleh M, Chenna V, Contractor H, Krishna Mohan G, Tirumandyam G, Dammas N Cureus. 2023; 15(4):e38135.

PMID: 37252463 PMC: 10213992. DOI: 10.7759/cureus.38135.


Effects of Hydroxyurea on Skeletal Muscle Energetics and Function in a Mildly Anemic Mouse Model.

Michel C, Messonnier L, Giannesini B, Chatel B, Vilmen C, Fur Y Front Physiol. 2022; 13:915640.

PMID: 35784862 PMC: 9240423. DOI: 10.3389/fphys.2022.915640.


Hydroxyurea (hydroxycarbamide) for transfusion-dependent β-thalassaemia.

Ansari S, Lassi Z, Khowaja S, Adil S, Shamsi T Cochrane Database Syst Rev. 2019; 3:CD012064.

PMID: 30882896 PMC: 6421980. DOI: 10.1002/14651858.CD012064.pub2.


Emerging Therapies.

Guerra A, Musallam K, Taher A, Rivella S Hematol Oncol Clin North Am. 2018; 32(2):343-352.

PMID: 29458736 PMC: 5823282. DOI: 10.1016/j.hoc.2017.11.002.


Treating hemoglobinopathies using gene-correction approaches: promises and challenges.

Cottle R, Lee C, Bao G Hum Genet. 2016; 135(9):993-1010.

PMID: 27314256 PMC: 5002253. DOI: 10.1007/s00439-016-1696-0.